Welcome to our dedicated page for Innovate news (Ticker: VATE), a resource for investors and traders seeking the latest updates and insights on Innovate stock.
INNOVATE Corp. (NYSE: VATE) generates news across its three reported segments: Infrastructure, Life Sciences and Spectrum. As a holding company with operating subsidiaries and equity method investments, its disclosures cover developments in structural steel construction, medical technology, aesthetic devices and over-the-air broadcasting.
News about the Infrastructure segment often focuses on DBM Global Inc., a family of companies providing integrated steel construction services. Coverage includes project activity, revenue by segment, backlog levels and cash dividends paid by DBM Global to its stockholders, with INNOVATE identified as the largest stockholder.
In Life Sciences, INNOVATE’s news highlights regulatory and commercial milestones at portfolio companies such as MediBeacon Inc. and R2 Technologies, Inc. Releases have detailed U.S. Food and Drug Administration approval for MediBeacon’s TGFR system, approvals in China for the Transdermal GFR System and Lumitrace injection, and growth in R2’s Glacial Skin CryoAesthetics platforms and global system sales.
The Spectrum segment generates updates on broadcasting operations, including revenue trends, new network launches and datacasting initiatives using ATSC 3.0 technology. INNOVATE has reported on the launch of ATSC 3.0 stations for a large mobile carrier and efforts to expand reach with additional networks.
Investors and followers of VATE can use this news feed to review INNOVATE’s quarterly earnings releases, Form 8-K announcements, refinancing transactions, segment performance commentary and major events at DBM Global, MediBeacon and R2. Regular updates provide a consolidated view of how developments in each segment contribute to the overall INNOVATE portfolio.
INNOVATE Corp. (NYSE: VATE) has announced an extension of the effective date for its 1-for-10 reverse stock split to August 8, 2024, after the close of trading on the NYSE. The stock is expected to begin trading on a split-adjusted basis on August 9, 2024. This move aims to increase the per share market price to meet the NYSE's minimum bid price requirement for continued listing. The reverse split, approved by stockholders on June 18, 2024, will reclassify every ten shares into one new share. Adjustments will be made to outstanding equity awards and convertible securities. The number of authorized shares and par value will remain unchanged. Computershare, Inc. is acting as the exchange agent for the split.
INNOVATE Corp. (NYSE: VATE) has announced a 1-for-10 reverse stock split of its common stock, effective August 2, 2024. The primary goal is to increase the per share market price to meet the NYSE's minimum bid price requirement for continued listing. Trading on a split-adjusted basis will commence on August 5, 2024, under the existing symbol 'VATE'.
Key points:
- Every ten shares will be reclassified into one new share
- Adjustments will be made to outstanding equity awards and convertible securities
- The number of authorized shares and par value remain unchanged
- Computershare is acting as the exchange agent
- Stockholders with book-entry shares need not take action; those with certificates must turn them in
INNOVATE Corp. (NYSE: VATE) has announced it will release its second quarter 2024 financial results on August 7, 2024, after market close. The company will host an earnings conference call on the same day at 4:30 p.m. ET to review the results, operations, and strategy.
Investors can access the live call through INNOVATE's Investor Relations website at www.innovate-ir.com. For those unable to listen live, a replay will be available shortly after the call on the same website. The conference call can be accessed via phone using the following details:
- Domestic Dial-In: 1-800-717-1738
- Toll/International: 1-646-307-1865
- Conference Number: 1133462
The conference replay will be available until August 20, 2024.
INNOVATE Corp. announced first quarter 2024 results, with $315.2 million in revenue, a 0.8% decrease from the previous year. Net loss was $17.7 million, a 73.5% increase, with $12.8 million Adjusted EBITDA, up 161.2%. DBM Global had $307.9 million in revenue, R2 had record North America sales, and Broadcasting saw revenue growth from new network launches.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.